We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-0.93%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.52B
AUM Growth
-$149M
Cap. Flow
-$56.4M
Cap. Flow %
-3.71%
Top 10 Hldgs %
43.87%
Holding
86
New
7
Increased
23
Reduced
23
Closed
3

Top Buys

Rank Stock Value
1
BCYC
Bicycle Therapeutics
BCYC
+$25.6M
2
PHLT
Performant Healthcare Inc
PHLT
+$19.6M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$19.2M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$15.7M
5
MXCT icon
MaxCyte
MXCT
+$15M

Top Sells

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$38.6M
2
GKOS icon
Glaukos
GKOS
+$34.7M
3
PRTA icon
Prothena Corp
PRTA
+$29.7M
4
HALO icon
Halozyme
HALO
+$23.9M
5
GMAB icon
Genmab
GMAB
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 80.69%
2 Communication Services 5.47%
3 Consumer Discretionary 0.55%
4 Energy 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
76
AbbVie
ABBV
$443B
$403K 0.03%
3,740
– –
CI icon
77
Cigna
CI
$73.7B
$389K 0.03%
1,943
– –
PFE icon
78
Pfizer
PFE
$143B
$364K 0.02%
8,469
– –
JNJ icon
79
Johnson & Johnson
JNJ
$618B
$349K 0.02%
2,161
– –
SNY icon
80
Sanofi
SNY
$103B
$321K 0.02%
6,650
– –
UHS icon
81
Universal Health Services
UHS
$10.2B
$284K 0.02%
2,050
– –
MCK icon
82
McKesson
MCK
$100B
$268K 0.02%
1,346
– –
EBS icon
83
Emergent Biosolutions
EBS
$373M
$215K 0.01%
4,294
– –
ARWR icon
84
Arrowhead Research
ARWR
$11.9B
– –
-465,572
Closed -$38.6M
FATE icon
85
Fate Therapeutics
FATE
$286M
– –
-15,400
Closed -$1.34M
GKOS icon
86
Glaukos
GKOS
$9.83B
– –
-409,144
Closed -$34.7M
1 2 3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, First Light Asset Management held 86 positions worth $1.52B, down 8.9% from $1.67B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

First Light Asset Management withdrew a net $56.4M in Q3 2021, closing 3 positions and reducing 23 holdings. Its most notable exit was Arrowhead Research, an estimated $38.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 84% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, First Light Asset Management opened a new position in Bicycle Therapeutics worth $30.5M.

  • First Light Asset Management's largest Q3 2021 buy was Bicycle Therapeutics: 732,731 shares worth $30.5M.
  • First Light Asset Management added most to Ultragenyx Pharmaceutical in Q3 2021, an estimated $19.2M increase.
  • First Light Asset Management's biggest Q3 2021 reduction was Prothena Corp, cutting an estimated $29.7M.
  • First Light Asset Management fully exited Arrowhead Research in Q3 2021, selling an estimated $38.6M.
  • First Light Asset Management's ten largest holdings make up 44% of its $1.52B portfolio in Q3 2021.
  • First Light Asset Management opened 7 new positions and closed 3 in Q3 2021.
  • First Light Asset Management's portfolio value fell 8.9% quarter-over-quarter to $1.52B.

Based on First Light Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.